On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.54 USD | -1.89% | -5.83% | -19.04% |
May. 23 | Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment | MT |
May. 22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.04% | 84.21B | |
+38.69% | 728B | |
+34.28% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+17.02% | 244B | |
+9.31% | 207B | |
-5.07% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company